|
|
| Regel 29: |
Regel 29: |
| |}<section end=XXX_Amaya /> | | |}<section end=XXX_Amaya /> |
| ===Medicatieafspraken XXX_Amaya === | | ===Medicatieafspraken XXX_Amaya === |
| <section begin=MA_XXX_Amaya /> | | <section begin=MA_XXX_Amaya /><section end=MA_XXX_Amaya /> |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_513_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 1 dag, om 11:25
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 1 dag, gedurende 1 jaar
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geannuleerd indicator
| |
| |style="background-color: white;"|false
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Reden afspraak
| |
| |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 1 dag, gedurende 1 jaar, 10 maal per dag 1 stuk, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|10 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_513_1
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_513_1_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T, om 09:00
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T, gedurende 1 jaar
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Reden afspraak
| |
| |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T, gedurende 1 jaar, 1 maal per dag 1 stuk, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_513_1
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_513_2_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T, om 14:32
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar afspraak of gebruik: TA
| |
| |style="background-color: white;"|MBH_513_2_TA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Reden afspraak
| |
| |style="background-color: white;"|Opname (code = '305335007' in codeSystem 'SNOMED CT')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Toelichting
| |
| |style="background-color: white;"|Toedieningsafspraak van apotheker ontvangen, geen medicatieafspraak van voorschrijver ontvangen. Deze nieuwe medicatieafspraak is gebaseerd op de toedieningsafspraak: MBH_513_2_TA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_513_2
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_513_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T, om 14:32
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T, gedurende 28 dagen
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar afspraak of gebruik: MGB
| |
| |style="background-color: white;"|MBH_513_3_MGB_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Reden afspraak
| |
| |style="background-color: white;"|Opname (code = '305335007' in codeSystem 'SNOMED CT')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Reden van voorschrijven
| |
| |style="background-color: white;"|Andere maligniteit bloed/lymfestelsel (code = 'B74' in codeSystem 'De Nederlandse editie van International Classification of Primary Care ICPC-1-NL')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T, gedurende 28 dagen, 1 maal per week 5 stuks, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per week 5 stuks
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_513_3
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_513_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 5 dagen, om 09:35
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Reden afspraak
| |
| |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|3 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Lichaamslengte
| |
| |style="background-color: white;"|155 cm. Gemeten: T- 5 dagen, om 09:35
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Lichaamsgewicht
| |
| |style="background-color: white;"|54 kg. Gemeten: T- 5 dagen, om 09:35
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Aanvullende informatie
| |
| |style="background-color: white;"|Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Toelichting
| |
| |style="background-color: white;"|In overleg met specialist
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_513_4
| |
| |}<section end=MA_XXX_Amaya />
| |
| ===Verstrekkingsverzoeken XXX_Amaya === | | ===Verstrekkingsverzoeken XXX_Amaya === |
| <section begin=VV_XXX_Amaya /> | | <section begin=VV_XXX_Amaya /> |
| Regel 336: |
Regel 104: |
| |}<section end=VV_XXX_Amaya /> | | |}<section end=VV_XXX_Amaya /> |
| ===Toedieningsafspraken XXX_Amaya === | | ===Toedieningsafspraken XXX_Amaya === |
| <section begin=TA_XXX_Amaya /> | | <section begin=TA_XXX_Amaya /><section end=TA_XXX_Amaya /> |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_513_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T, om 12:25
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T, gedurende 1 jaar
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geannuleerd indicator
| |
| |style="background-color: white;"|true
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Verstrekker
| |
| |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|ASPIRINE PROTECT EC TABLET MSR 100MG (code = '1110837' in codeSystem 'G-Standaard HPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T, gedurende 1 jaar, 1 maal per dag 1 stuk, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar medicatieafspraak
| |
| |style="background-color: white;"|MBH_513_1_MA_2
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_513_1
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_513_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 7 dagen, om 14:52
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 7 dagen, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Verstrekker
| |
| |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Reden afspraak
| |
| |style="background-color: white;"|Opname
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|FUROSEMIDE ACTAVIS TABLET 40MG (code = '571148' in codeSystem 'G-Standaard HPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 7 dagen, tot nader order, 1 maal per dag 1 stuk, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar medicatieafspraak
| |
| |style="background-color: white;"|MBH_513_2_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_513_2
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_513_4_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 5 dagen, om 09:45
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Verstrekker
| |
| |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|AMOXICILLINE PCH CAPSULE 500MG (code = '646083' in codeSystem 'G-Standaard HPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 10 dagen, 3 maal per dag 1 stuk, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|3 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Aanvullende informatie
| |
| |style="background-color: white;"|Gebruiksinstructie gegeven (code = '10' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2053')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Toelichting
| |
| |style="background-color: white;"|Wegens niet leverbaar zijn van Broxil
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar medicatieafspraak
| |
| |style="background-color: white;"|MBH_513_4_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_513_4
| |
| |}<section end=TA_XXX_Amaya />
| |
| ===Verstrekkingen XXX_Amaya === | | ===Verstrekkingen XXX_Amaya === |
| <section begin=MVE_XXX_Amaya /> | | <section begin=MVE_XXX_Amaya /> |
| Regel 540: |
Regel 173: |
| |}<section end=MVE_XXX_Amaya /> | | |}<section end=MVE_XXX_Amaya /> |
| ===Medicatiegebruik XXX_Amaya === | | ===Medicatiegebruik XXX_Amaya === |
| <section begin=MGB_XXX_Amaya /> | | <section begin=MGB_XXX_Amaya /><section end=MGB_XXX_Amaya /> |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_513_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Registratiedatum
| |
| |style="background-color: white;"|T- 2 dagen, om 15:39
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruik indicator
| |
| |style="background-color: white;"|true
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 2 dagen, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 2 dagen, tot nader order, 1 maal per dag 1 stuk, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gerelateerde afspraak : MA
| |
| |style="background-color: white;"|MBH_513_2_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Informant
| |
| |style="background-color: white;"|Patiënt
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Auteur
| |
| |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_513_2
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_513_2_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Registratiedatum
| |
| |style="background-color: white;"|T, om 20:40
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruik indicator
| |
| |style="background-color: white;"|true
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 1 dag, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 1 dag, tot nader order, 1 maal per dag 1 stuk, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gerelateerde afspraak : MA
| |
| |style="background-color: white;"|MBH_513_2_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Informant
| |
| |style="background-color: white;"|Persoon: M. XXX_Amaya - Mantelzorger.
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Auteur
| |
| |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_513_2
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_513_2_MGB_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Registratiedatum
| |
| |style="background-color: white;"|T, om 21:39
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruik indicator
| |
| |style="background-color: white;"|true
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|Furosemide tablet 40mg (code = '5967' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T, tot nader order, 1 maal per dag 1 stuk, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gerelateerde afspraak : MA
| |
| |style="background-color: white;"|MBH_513_2_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Informant
| |
| |style="background-color: white;"|Zorgverlener: Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Auteur
| |
| |style="background-color: white;"|Zorgverlener: Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_513_2
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_5132_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Registratiedatum
| |
| |style="background-color: white;"|T, om 20:59
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruik indicator
| |
| |style="background-color: white;"|true
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T, gedurende 1 dag
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|TEMAZEPAM APOTEX TABLET 10MG (code = '13806769' in codeSystem 'G-Standaard ZI-nummer')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T, gedurende 1 dag, 1 maal per dag 1 stuk, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gerelateerde verstrekking
| |
| |style="background-color: white;"|MBH_5132_2_MVE_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Auteur
| |
| |style="background-color: white;"|Patiënt
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_5132_2
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_513_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Registratiedatum
| |
| |style="background-color: white;"|T- 3 dagen, om 20:59
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruik indicator
| |
| |style="background-color: white;"|true
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Hans van Doorn - Medisch specialisten, inwendige geneeskunde. Ziekenhuis Stitswerd
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '6009' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="3"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 8 dagen, tot en met T- 3 dagen, om 23:59, 1 maal per week 5 stuks, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per week 5 stuks
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gerelateerde afspraak : MA
| |
| |style="background-color: white;"|MBH_513_3_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Auteur
| |
| |style="background-color: white;"|Patiënt
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Reden gebruik
| |
| |style="background-color: white;"|Lymfekanker
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_513_3
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_513_4_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Registratiedatum
| |
| |style="background-color: white;"|T- 4 dagen, om 22:35
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruik indicator
| |
| |style="background-color: white;"|true
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Volgens afspraak indicator
| |
| |style="background-color: white;"|false
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 5 dagen, tot en met T- 4 dagen, om 23:59, 1 maal per dag 1 stuk, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gerelateerde afspraak : MA
| |
| |style="background-color: white;"|MBH_513_4_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Auteur
| |
| |style="background-color: white;"|Patiënt
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_513_4
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_513_4_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Registratiedatum
| |
| |style="background-color: white;"|T- 3 dagen, om 22:35
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruik indicator
| |
| |style="background-color: white;"|false
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Volgens afspraak indicator
| |
| |style="background-color: white;"|false
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 3 dagen, gedurende 1 dag
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Stoptype
| |
| |style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="2"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 3 dagen, gedurende 1 dag, 0 stuks
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gerelateerde afspraak : MA
| |
| |style="background-color: white;"|MBH_513_4_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gerelateerde afspraak : TA
| |
| |style="background-color: white;"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gerelateerde verstrekking
| |
| |style="background-color: white;"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Auteur
| |
| |style="background-color: white;"|Patiënt
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_513_4
| |
| |}<section end=MGB_XXX_Amaya />
| |
| ==Patiënt Pauline P. XXX_Bourgonje== | | ==Patiënt Pauline P. XXX_Bourgonje== |
| <section begin=XXX_Bourgonje /> | | <section begin=XXX_Bourgonje /> |
| Regel 901: |
Regel 199: |
| |}<section end=XXX_Bourgonje /> | | |}<section end=XXX_Bourgonje /> |
| ===Medicatieafspraken XXX_Bourgonje === | | ===Medicatieafspraken XXX_Bourgonje === |
| <section begin=MA_XXX_Bourgonje /> | | <section begin=MA_XXX_Bourgonje /><section end=MA_XXX_Bourgonje /> |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_123_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 7 dagen
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 7 dagen, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Reden afspraak
| |
| |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-StandaardGPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="5"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 7 dagen, tot nader order, Zo nodig 2 maal daags aanbrengen, op de huid
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Aanvullende instructie
| |
| |style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|zo nodig 2 maal per dag
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_123_1
| |
| |}<section end=MA_XXX_Bourgonje />
| |
| ===Verstrekkingsverzoeken XXX_Bourgonje === | | ===Verstrekkingsverzoeken XXX_Bourgonje === |
| <section begin=VV_XXX_Bourgonje /> | | <section begin=VV_XXX_Bourgonje /> |
| Regel 980: |
Regel 234: |
| |}<section end=VV_XXX_Bourgonje /> | | |}<section end=VV_XXX_Bourgonje /> |
| ===Toedieningsafspraken XXX_Bourgonje === | | ===Toedieningsafspraken XXX_Bourgonje === |
| <section begin=TA_XXX_Bourgonje /> | | <section begin=TA_XXX_Bourgonje /><section end=TA_XXX_Bourgonje /> |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_123_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 7 dagen
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 7 dagen, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Verstrekker
| |
| |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-Standaard HPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="5"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 7 dagen, tot nader order, Zo nodig 2 maal daags aanbrengen, op de huid
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Aanvullende instructie
| |
| |style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|zo nodig 2 maal per dag
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar medicatieafspraak
| |
| |style="background-color: white;"|MBH_123_1_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_123_1
| |
| |}<section end=TA_XXX_Bourgonje />
| |
| ===Verstrekkingen XXX_Bourgonje === | | ===Verstrekkingen XXX_Bourgonje === |
| <section begin=MVE_XXX_Bourgonje /> | | <section begin=MVE_XXX_Bourgonje /> |
| Regel 1.056: |
Regel 266: |
| |}<section end=MVE_XXX_Bourgonje /> | | |}<section end=MVE_XXX_Bourgonje /> |
| ===Medicatiegebruik XXX_Bourgonje === | | ===Medicatiegebruik XXX_Bourgonje === |
| <section begin=MGB_XXX_Bourgonje /> | | <section begin=MGB_XXX_Bourgonje /><section end=MGB_XXX_Bourgonje /> |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_123_1_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Registratiedatum
| |
| |style="background-color: white;"|T- 4 dagen, om 20:58
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruik indicator
| |
| |style="background-color: white;"|true
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 5 dagen, gedurende 2 dagen
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Bertine van Doorn - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Stitswerd Oost
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-StandaardGPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="3"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Aanvullende instructie
| |
| |style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|2 maal per dag
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gerelateerde afspraak : MA
| |
| |style="background-color: white;"|MBH_123_1_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Auteur
| |
| |style="background-color: white;"|Patiënt
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_123_1
| |
| |}<section end=MGB_XXX_Bourgonje />
| |
| ==Patiënt J. XXX_Cnossen== | | ==Patiënt J. XXX_Cnossen== |
| <section begin=XXX_Cnossen /> | | <section begin=XXX_Cnossen /> |
| Regel 1.126: |
Regel 292: |
| |}<section end=XXX_Cnossen /> | | |}<section end=XXX_Cnossen /> |
| ===Medicatieafspraken XXX_Cnossen === | | ===Medicatieafspraken XXX_Cnossen === |
| <section begin=MA_XXX_Cnossen /> | | <section begin=MA_XXX_Cnossen /><section end=MA_XXX_Cnossen /> |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_313_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 100 dagen, om 12:11
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 100 dagen, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Reden afspraak
| |
| |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug (code = '59919' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 100 dagen, tot nader order, 1 maal per dag 1 inhalatie, inhalatie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 dosis
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_313_1
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_313_1_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 60 dagen, om 13:54
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 59 dagen, om 23:59
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Stoptype
| |
| |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Reden afspraak
| |
| |style="background-color: white;"|Indicatie vervallen (code = '9' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug (code = '59919' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 59 dagen, om 23:59, 1 maal per dag 1 dosis, inhalatie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 dosis
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_313_1
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_313_2_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 500 dagen, om 10:19
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 500 dagen, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Reden afspraak
| |
| |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="5"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 500 dagen, tot nader order, 1x per dag 1 druppel, in beide ogen
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Aanvullende instructie
| |
| |style="background-color: white;"|in beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 druppel
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_313_2
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_313_2_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 366 dagen, om 17:54
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 500 dagen, tot en met T- 366 dagen, om 17:00
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Stoptype
| |
| |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Reden afspraak
| |
| |style="background-color: white;"|Indicatie vervallen (code = '9' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="5"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 500 dagen, tot en met T- 366 dagen, om 17:00, Vanaf 21 apr 2017 tot en met 2 sep 2017 17:00, 1x per dag 1 druppel, in beide ogen
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Aanvullende instructie
| |
| |style="background-color: white;"|in beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 druppel
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_313_2
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_313_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 100 dagen, om 12:11
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 100 dagen, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Reden afspraak
| |
| |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO (code = '13072' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 100 dagen, tot nader order, 1 maal per dag 1 stuk, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_313_3
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_313_3_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 4 dagen, om 13:54
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 5 dagen, om 23:59
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Stoptype
| |
| |style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO (code = '13072' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 5 dagen, om 23:59, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_313_3
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_313_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 300 dagen, om 14:23
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 300 dagen, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Reden afspraak
| |
| |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|Omeprazol tablet MSR 40mg (code = '88803' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 300 dagen, tot nader order, 1 maal per dag 1 stuk, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_313_4
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_313_4_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 222 dagen, om 08:54
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 300 dagen, tot en met T- 223 dagen, om 23:59
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Stoptype
| |
| |style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|Omeprazol tablet MSR 40mg (code = '88803' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 300 dagen, tot en met T- 223 dagen, om 23:59, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_313_4
| |
| |}<section end=MA_XXX_Cnossen />
| |
| ===Toedieningsafspraken XXX_Cnossen === | | ===Toedieningsafspraken XXX_Cnossen === |
| <section begin=TA_XXX_Cnossen /> | | <section begin=TA_XXX_Cnossen /><section end=TA_XXX_Cnossen /> |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_313_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 100 dagen, om 12:11
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 100 dagen, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Verstrekker
| |
| |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|SPIRIVA INHALPDR 18MCG (code = '1476866' in codeSystem 'G-Standaard HPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 100 dagen, tot nader order, 1 maal per dag 1 inhalatie, inhalatie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 dosis
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar medicatieafspraak
| |
| |style="background-color: white;"|MBH_313_1_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_313_1
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_313_1_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 60 dagen, om 13:54
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 59 dagen, om 23:59
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Stoptype
| |
| |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Verstrekker
| |
| |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|SPIRIVA INHALPDR 18MCG (code = '1476866' in codeSystem 'G-Standaard HPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 59 dagen, om 23:59, 1 maal per dag 1 dosis, inhalatie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 dosis
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar medicatieafspraak
| |
| |style="background-color: white;"|MBH_313_1_MA_2
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_313_1
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_313_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 500 dagen, om 10:19
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 500 dagen, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Verstrekker
| |
| |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|LATANOPROST/TIMOLOL SDZ OOGDR 0,05/5MG/ML FL 2,5ML (code = '2226294' in codeSystem 'G-Standaard HPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="5"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 500 dagen, tot nader order, 1x per dag 1 druppel, in beide ogen
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Aanvullende instructie
| |
| |style="background-color: white;"|in beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 druppel
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar medicatieafspraak
| |
| |style="background-color: white;"|MBH_313_2_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_313_2
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_313_2_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 366 dagen, om 17:54
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 500 dagen, tot en met T- 366 dagen, om 17:00
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Stoptype
| |
| |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Verstrekker
| |
| |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|LATANOPROST/TIMOLOL SDZ OOGDR 0,05/5MG/ML FL 2,5ML (code = '2226294' in codeSystem 'G-Standaard HPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="5"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 500 dagen, tot en met T- 366 dagen, om 17:00, 1x per dag 1 druppel, in beide ogen
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Aanvullende instructie
| |
| |style="background-color: white;"|in beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 druppel
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar medicatieafspraak
| |
| |style="background-color: white;"|MBH_313_2_MA_2
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_313_2
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_313_3_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 100 dagen, om 12:30
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 100 dagen, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Verstrekker
| |
| |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|CARBASALAATCALCIUM CF SACHET 100MG (code = '1113534' in codeSystem 'G-Standaard HPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 100 dagen, tot nader order, 1 maal per dag 1 stuk, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar medicatieafspraak
| |
| |style="background-color: white;"|MBH_313_3_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_313_3
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_313_3_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 4 dagen, om 14:54
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 5 dagen, om 23:59
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Stoptype
| |
| |style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Verstrekker
| |
| |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|CARBASALAATCALCIUM CF SACHET 100MG (code = '1113534' in codeSystem 'G-Standaard HPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 100 dagen, tot en met T- 5 dagen, om 23:59, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar medicatieafspraak
| |
| |style="background-color: white;"|MBH_313_3_MA_2
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_313_3
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_313_4_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 300 dagen, om 15:23
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 300 dagen, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Verstrekker
| |
| |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|OMEPRAZOL SANDOZ MUT TABLET MSR 40MG (code = '2124971' in codeSystem 'G-Standaard HPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 300 dagen, tot nader order, 1 maal per dag 1 stuk, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar medicatieafspraak
| |
| |style="background-color: white;"|MBH_313_4_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_313_4
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_313_4_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 222 dagen, om 09:54
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 300 dagen, tot en met T- 223 dagen, om 23:59
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Stoptype
| |
| |style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Verstrekker
| |
| |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|OMEPRAZOL SANDOZ MUT TABLET MSR 40MG (code = '2124971' in codeSystem 'G-Standaard HPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 300 dagen, tot en met T- 223 dagen, om 23:59, 1 maal per dag 1 stuk, oraal – tijdelijk onderbreken
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar medicatieafspraak
| |
| |style="background-color: white;"|MBH_313_4_MA_2
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_313_4
| |
| |}<section end=TA_XXX_Cnossen />
| |
| ===Medicatiegebruik XXX_Cnossen === | | ===Medicatiegebruik XXX_Cnossen === |
| <section begin=MGB_XXX_Cnossen /> | | <section begin=MGB_XXX_Cnossen /><section end=MGB_XXX_Cnossen /> |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_313_1_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Registratiedatum
| |
| |style="background-color: white;"|T- 59 dagen, om 12:11
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruik indicator
| |
| |style="background-color: white;"|true
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 59 dagen, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug (code = '59919' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 59 dagen, tot nader order, 1 maal per dag 1 dosis
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 dosis
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gerelateerde afspraak : MA
| |
| |style="background-color: white;"|MBH_313_1_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Auteur
| |
| |style="background-color: white;"|Patiënt
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_313_1
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_313_1_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Registratiedatum
| |
| |style="background-color: white;"|7 jul 2018, om 15:25
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruik indicator
| |
| |style="background-color: white;"|false
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Volgens afspraak indicator
| |
| |style="background-color: white;"|true
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf 7 jul 2018, om 07:00, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Stoptype
| |
| |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|Tiotropium inhalatiecapsule 18ug (code = '59919' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="2"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf 7 jul 2018, om 07:00, tot nader order, Vanaf 7 juli, geen gebruik
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gerelateerde afspraak : MA
| |
| |style="background-color: white;"|MBH_313_1_MA_2
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Auteur
| |
| |style="background-color: white;"|Patiënt
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_313_1
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_313_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Registratiedatum
| |
| |style="background-color: white;"|21 apr 2017, om 10:19
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruik indicator
| |
| |style="background-color: white;"|true
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Volgens afspraak indicator
| |
| |style="background-color: white;"|true
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf 21 apr 2017, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="5"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf 21 apr 2017, tot nader order, 1x per dag 1 druppel, in beide ogen
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Aanvullende instructie
| |
| |style="background-color: white;"|in beide ogen (code = '1026' in codeSystem 'NHG tabel 25 aanvullende teksten')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 druppel
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gerelateerde afspraak : MA
| |
| |style="background-color: white;"|MBH_313_2_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Auteur
| |
| |style="background-color: white;"|Patiënt
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_313_2
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_313_2_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Registratiedatum
| |
| |style="background-color: white;"|T- 365 dagen, om 17:54
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruik indicator
| |
| |style="background-color: white;"|false
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Volgens afspraak indicator
| |
| |style="background-color: white;"|true
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 366 dagen, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Stoptype
| |
| |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|Timolol/Latanoprost oogdr 5mg/50ug/ml fl 2,5ml (code = '60526' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="2"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 366 dagen, tot nader order, geen gebruik
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gerelateerde afspraak : MA
| |
| |style="background-color: white;"|MBH_313_2_MA_2
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Auteur
| |
| |style="background-color: white;"|Patiënt
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_313_2
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_313_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Registratiedatum
| |
| |style="background-color: white;"|26 mei 2018, om 14:11
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruik indicator
| |
| |style="background-color: white;"|true
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Volgens afspraak indicator
| |
| |style="background-color: white;"|true
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf 26 mei 2018, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO (code = '13072' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf 26 mei 2018, tot nader order, 1 maal per dag 1 stuk, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gerelateerde afspraak : MA
| |
| |style="background-color: white;"|MBH_313_3_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Auteur
| |
| |style="background-color: white;"|Patiënt
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_313_3
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_313_3_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Registratiedatum
| |
| |style="background-color: white;"|29 aug 2018, om 13:54
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruik indicator
| |
| |style="background-color: white;"|false
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Volgens afspraak indicator
| |
| |style="background-color: white;"|true
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf 29 aug 2018, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Stoptype
| |
| |style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|CARBASALAATCALCIUM 100MG PO (code = '13072' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="2"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf 29 aug 2018, tot nader order, gebruik onderbroken
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gerelateerde afspraak : MA
| |
| |style="background-color: white;"|MBH_313_3_MA_2
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Auteur
| |
| |style="background-color: white;"|Patiënt
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_313_3
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_313_4_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Registratiedatum
| |
| |style="background-color: white;"|7 nov 2017, om 17:23
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruik indicator
| |
| |style="background-color: white;"|false
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf 7 nov 2017, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|Omeprazol tablet MSR 40mg (code = '88803' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf 7 nov 2017, tot nader order, 1 maal per dag 1 stuk, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gerelateerde afspraak : MA
| |
| |style="background-color: white;"|MBH_313_4_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Auteur
| |
| |style="background-color: white;"|Patiënt
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_313_4
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_313_4_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Registratiedatum
| |
| |style="background-color: white;"|T- 222 dagen, om 19:35
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruik indicator
| |
| |style="background-color: white;"|false
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Volgens afspraak indicator
| |
| |style="background-color: white;"|true
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 222 dagen, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Stoptype
| |
| |style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|Omeprazol tablet MSR 40mg (code = '88803' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="2"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 222 dagen, tot nader order, gebruik onderbroken
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gerelateerde afspraak : MA
| |
| |style="background-color: white;"|MBH_313_4_MA_2
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Auteur
| |
| |style="background-color: white;"|Patiënt
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_313_4
| |
| |}<section end=MGB_XXX_Cnossen />
| |
| ==Patiënt R. XXX_Dirksz== | | ==Patiënt R. XXX_Dirksz== |
| <section begin=XXX_Dirksz /> | | <section begin=XXX_Dirksz /> |
| Regel 2.227: |
Regel 322: |
| |}<section end=XXX_Dirksz /> | | |}<section end=XXX_Dirksz /> |
| ===Medicatieafspraken XXX_Dirksz === | | ===Medicatieafspraken XXX_Dirksz === |
| <section begin=MA_XXX_Dirksz /> | | <section begin=MA_XXX_Dirksz /><section end=MA_XXX_Dirksz /> |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_113_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 50 dagen, om 11:25
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 30 dagen
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Reden afspraak
| |
| |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|Metoclopramide zetpil 20mg (code = '6939' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 30 dagen, zo nodig 1 maal per dag 1 stuk, rectaal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Rectaal (code = '12' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|zo nodig 1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_113_1
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_113_2_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 30 dagen, om 14:55
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 30 dagen, gedurende 3 weken
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Reden afspraak
| |
| |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|Zestril tabel 10mg (code = '615560' in codeSystem 'G-Standaard HPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 30 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_113_2
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_113_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 30 dagen, om 14:57
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 30 dagen, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Reden afspraak
| |
| |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 30 dagen, tot nader order, 1 maal per dag 1 stuk, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_113_3
| |
| |}<section end=MA_XXX_Dirksz />
| |
| ===Verstrekkingsverzoeken XXX_Dirksz === | | ===Verstrekkingsverzoeken XXX_Dirksz === |
| <section begin=VV_XXX_Dirksz /> | | <section begin=VV_XXX_Dirksz /> |
| Regel 2.447: |
Regel 419: |
| |}<section end=VV_XXX_Dirksz /> | | |}<section end=VV_XXX_Dirksz /> |
| ===Toedieningsafspraken XXX_Dirksz === | | ===Toedieningsafspraken XXX_Dirksz === |
| <section begin=TA_XXX_Dirksz /> | | <section begin=TA_XXX_Dirksz /><section end=TA_XXX_Dirksz /> |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_113_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 50 dagen, om 11:25
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 30 dagen
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Verstrekker
| |
| |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|PRIMPERAN ZETPIL 20MG (code = '229709' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 30 dagen, zo nodig 1 maal per dag 1 stuk, rectaal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Rectaal (code = '12' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|zo nodig 1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar medicatieafspraak
| |
| |style="background-color: white;"|MBH_113_1_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_113_1
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_113_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 30 dagen, om 14:55
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 30 dagen, gedurende 3 weken
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Verstrekker
| |
| |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|Zestril tabel 10mg (code = '615560' in codeSystem 'G-Standaard HPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 30 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar medicatieafspraak
| |
| |style="background-color: white;"|MBH_113_2_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_113_2
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_113_3_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 30 dagen, om 14:57
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 30 dagen, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Verstrekker
| |
| |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 30 dagen, tot nader order, 1 maal per dag 1 stuk, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar medicatieafspraak
| |
| |style="background-color: white;"|MBH_113_2_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_113_3
| |
| |}<section end=TA_XXX_Dirksz />
| |
| ===Verstrekkingen XXX_Dirksz === | | ===Verstrekkingen XXX_Dirksz === |
| <section begin=MVE_XXX_Dirksz /> | | <section begin=MVE_XXX_Dirksz /> |
| Regel 2.658: |
Regel 507: |
| |}<section end=MVE_XXX_Dirksz /> | | |}<section end=MVE_XXX_Dirksz /> |
| ===Medicatiegebruik XXX_Dirksz === | | ===Medicatiegebruik XXX_Dirksz === |
| <section begin=MGB_XXX_Dirksz /> | | <section begin=MGB_XXX_Dirksz /><section end=MGB_XXX_Dirksz /> |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_113_1_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Registratiedatum
| |
| |style="background-color: white;"|T- 48 dagen, om 11:25
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruik indicator
| |
| |style="background-color: white;"|true
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 48 dagen, gedurende 1 dag
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|Metoclopramide zetpil 20mg (code = '6939' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 48 dagen, gedurende 1 dag, zo nodig 1 maal per dag 1 stuk, rectaal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Rectaal (code = '12' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|zo nodig 1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gerelateerde afspraak : MA
| |
| |style="background-color: white;"|MBH_113_1_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Auteur
| |
| |style="background-color: white;"|Patiënt
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_113_1
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_113_2_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Registratiedatum
| |
| |style="background-color: white;"|T- 13 dagen, om 14:55
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruik indicator
| |
| |style="background-color: white;"|true
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Volgens afspraak indicator
| |
| |style="background-color: white;"|true
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 30 dagen, gedurende 3 weken
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|Zestril tabel 10mg (code = '615560' in codeSystem 'G-Standaard HPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 30 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gerelateerde afspraak : MA
| |
| |style="background-color: white;"|MBH_113_2_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Auteur
| |
| |style="background-color: white;"|Patiënt
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_113_2
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_113_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Registratiedatum
| |
| |style="background-color: white;"|T- 29 dagen, om 14:57
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruik indicator
| |
| |style="background-color: white;"|true
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 29 dagen, tot en met T- 8 dagen, om 23:59
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 29 dagen, tot en met T- 8 dagen, om 23:59, 1 maal per dag 1 stuk, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gerelateerde afspraak : MA
| |
| |style="background-color: white;"|MBH_113_3_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Auteur
| |
| |style="background-color: white;"|Patiënt
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_113_3
| |
| |}<section end=MGB_XXX_Dirksz />
| |
| ==Patiënt R. XXX_Gobee== | | ==Patiënt R. XXX_Gobee== |
| <section begin=XXX_Gobee /> | | <section begin=XXX_Gobee /> |
| Regel 2.828: |
Regel 533: |
| |}<section end=XXX_Gobee /> | | |}<section end=XXX_Gobee /> |
| ===Medicatieafspraken XXX_Gobee === | | ===Medicatieafspraken XXX_Gobee === |
| <section begin=MA_XXX_Gobee /> | | <section begin=MA_XXX_Gobee /><section end=MA_XXX_Gobee /> |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_213_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 50 dagen, om 11:25
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 50 dagen, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Reden afspraak
| |
| |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 50 dagen, tot nader order, 1 à 2 maal per dag 1 tablet, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|zo nodig 1 à 2 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_213_1
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_213_1_MA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 40 dagen, om 09:13
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 50 dagen, tot en met T- 41 dagen, om 23:59
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Stoptype
| |
| |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar afspraak of gebruik: MA
| |
| |style="background-color: white;"|MBH_213_1_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 50 dagen, tot en met T- 41 dagen, om 23:59, 1 à 2 maal per dag 1 tablet, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|zo nodig 1 à 2 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_213_1
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_213_1_MA_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 40 dagen, om 09:13
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 40 dagen, gedurende 30 dagen
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar afspraak of gebruik: MA
| |
| |style="background-color: white;"|MBH_213_1_MA_2
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Reden afspraak
| |
| |style="background-color: white;"|Geen of onvoldoende effect (code = '5' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 40 dagen, gedurende 30 dagen, 2 maal per dag 1 tablet, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|2 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_213_1
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_213_1_MA_4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 15 dagen, om 16:25
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 40 dagen, tot en met T- 15 dagen, om 23:59
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Stoptype
| |
| |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar afspraak of gebruik: MA
| |
| |style="background-color: white;"|MBH_213_1_MA_3
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 40 dagen, tot en met T- 15 dagen, om 23:59, 2 maal per dag 1 tablet, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|2 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_213_1
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_213_1_MA_5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 15 dagen, om 16:25
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 14 dagen, gedurende 30 dagen
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar afspraak of gebruik: MA
| |
| |style="background-color: white;"|MBH_213_1_MA_4
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Reden afspraak
| |
| |style="background-color: white;"|Wens patiënt (code = '12' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 14 dagen, gedurende 30 dagen, 1 maal per dag 1 tablet, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_213_1
| |
| |}<section end=MA_XXX_Gobee />
| |
| ===Verstrekkingsverzoeken XXX_Gobee === | | ===Verstrekkingsverzoeken XXX_Gobee === |
| <section begin=VV_XXX_Gobee /> | | <section begin=VV_XXX_Gobee /> |
| Regel 3.148: |
Regel 636: |
| |}<section end=VV_XXX_Gobee /> | | |}<section end=VV_XXX_Gobee /> |
| ===Toedieningsafspraken XXX_Gobee === | | ===Toedieningsafspraken XXX_Gobee === |
| <section begin=TA_XXX_Gobee /> | | <section begin=TA_XXX_Gobee /><section end=TA_XXX_Gobee /> |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_213_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 50 dagen, om 11:25
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 50 dagen, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Verstrekker
| |
| |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 50 dagen, tot nader order, 1 à 2 maal per dag 1 tablet, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|zo nodig 1 à 2 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar medicatieafspraak
| |
| |style="background-color: white;"|MBH_213_1_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_213_1
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_213_1_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 40 dagen, om 09:13
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 50 dagen, tot en met T- 41 dagen, om 23:59
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Stoptype
| |
| |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Verstrekker
| |
| |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 50 dagen, tot en met T- 41 dagen, om 23:59, 1 à 2 maal per dag 1 tablet, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|zo nodig 1 à 2 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar medicatieafspraak
| |
| |style="background-color: white;"|MBH_213_1_MA_2
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_213_1
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_213_1_TA_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 40 dagen, om 09:13
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 40 dagen, gedurende 30 dagen
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Verstrekker
| |
| |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 40 dagen, gedurende 30 dagen, 2 maal per dag 1 tablet, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|2 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar medicatieafspraak
| |
| |style="background-color: white;"|MBH_213_1_MA_3
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_213_1
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_213_1_TA_4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 15 dagen, om 16:25
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 40 dagen, tot en met T- 15 dagen, om 23:59
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Stoptype
| |
| |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Verstrekker
| |
| |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 40 dagen, tot en met T- 15 dagen, om 23:59, 2 maal per dag 1 tablet, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|2 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar medicatieafspraak
| |
| |style="background-color: white;"|MBH_213_1_MA_4
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_213_1
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_213_1_TA_5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 15 dagen, om 16:25
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 14 dagen, gedurende 30 dagen
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Verstrekker
| |
| |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 14 dagen, gedurende 30 dagen, 1 maal per dag 1 tablet, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar medicatieafspraak
| |
| |style="background-color: white;"|MBH_213_1_MA_5
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_213_1
| |
| |}<section end=TA_XXX_Gobee />
| |
| ===Verstrekkingen XXX_Gobee === | | ===Verstrekkingen XXX_Gobee === |
| <section begin=MVE_XXX_Gobee /> | | <section begin=MVE_XXX_Gobee /> |
| Regel 3.450: |
Regel 727: |
| |}<section end=MVE_XXX_Gobee /> | | |}<section end=MVE_XXX_Gobee /> |
| ===Medicatiegebruik XXX_Gobee === | | ===Medicatiegebruik XXX_Gobee === |
| <section begin=MGB_XXX_Gobee /> | | <section begin=MGB_XXX_Gobee /><section end=MGB_XXX_Gobee /> |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_213_1_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Registratiedatum
| |
| |style="background-color: white;"|T- 47 dagen, om 11:25
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruik indicator
| |
| |style="background-color: white;"|true
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 3 dagen
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 50 dagen, gedurende 3 dagen, 1 maal per dag 1 tablet, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gerelateerde afspraak : MA
| |
| |style="background-color: white;"|MBH_213_1_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Auteur
| |
| |style="background-color: white;"|Patiënt
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_213_1
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_213_1_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Registratiedatum
| |
| |style="background-color: white;"|T- 41 dagen, om 11:25
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruik indicator
| |
| |style="background-color: white;"|true
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 46 dagen, gedurende 6 dagen
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 46 dagen, gedurende 6 dagen, 2 maal per dag 1 tablet, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|2 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gerelateerde afspraak : MA
| |
| |style="background-color: white;"|MBH_213_1_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Auteur
| |
| |style="background-color: white;"|Patiënt
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_213_1
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_213_1_MGB_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Registratiedatum
| |
| |style="background-color: white;"|T- 35 dagen, om 19:25
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruik indicator
| |
| |style="background-color: white;"|true
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 40 dagen, gedurende 6 dagen
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 40 dagen, gedurende 6 dagen, 2 maal per dag 1 tablet, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|2 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gerelateerde afspraak : TA
| |
| |style="background-color: white;"|MBH_213_1_TA_3
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Auteur
| |
| |style="background-color: white;"|Patiënt
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_213_1
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_213_1_MGB_4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Registratiedatum
| |
| |style="background-color: white;"|T- 16 dagen, om 11:25
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruik indicator
| |
| |style="background-color: white;"|true
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 34 dagen, gedurende 19 dagen
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 34 dagen, gedurende 19 dagen, 2 maal per dag 1 tablet, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|2 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gerelateerde afspraak : MA
| |
| |style="background-color: white;"|MBH_213_1_MA_3
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Auteur
| |
| |style="background-color: white;"|Patiënt
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_213_1
| |
| |}
| |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_213_1_MGB_5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Registratiedatum
| |
| |style="background-color: white;"|T- 10 dagen, om 11:25
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruik indicator
| |
| |style="background-color: white;"|true
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 14 dagen, gedurende 5 dagen
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 14 dagen, gedurende 5 dagen, 1 maal per dag 1 tablet, oraal
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gerelateerde afspraak : MA
| |
| |style="background-color: white;"|MBH_213_1_MA_5
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Auteur
| |
| |style="background-color: white;"|Patiënt
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_213_1
| |
| |}<section end=MGB_XXX_Gobee />
| |
| ==Patiënt J. XXX_Kilkenny== | | ==Patiënt J. XXX_Kilkenny== |
| <section begin=XXX_Kilkenny /> | | <section begin=XXX_Kilkenny /> |
| Regel 3.708: |
Regel 753: |
| |}<section end=XXX_Kilkenny /> | | |}<section end=XXX_Kilkenny /> |
| ===Medicatieafspraken XXX_Kilkenny === | | ===Medicatieafspraken XXX_Kilkenny === |
| <section begin=MA_XXX_Kilkenny /> | | <section begin=MA_XXX_Kilkenny /><section end=MA_XXX_Kilkenny /> |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_323_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Afspraakdatum
| |
| |style="background-color: white;"|T- 5 dagen, om 15:34
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 20 dagen, tot en met T- 6 dagen, om 23:59
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Stoptype
| |
| |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar afspraak of gebruik: MA
| |
| |style="background-color: white;"|MBH_323_1_MGB_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Voorschrijver
| |
| |style="background-color: white;"|John de Vries - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|ADVIL BRUIS BRUISTABLET 400MG CITRUSSMAAK (code = '2121522' in codeSystem 'G-Standaard HPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 20 dagen, tot en met T- 6 dagen, om 23:59, 3x per dag 1 tablet
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|3 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_323_1
| |
| |}<section end=MA_XXX_Kilkenny />
| |
| ===Medicatiegebruik XXX_Kilkenny === | | ===Medicatiegebruik XXX_Kilkenny === |
| <section begin=MGB_XXX_Kilkenny /> | | <section begin=MGB_XXX_Kilkenny /><section end=MGB_XXX_Kilkenny /> |
| {| class="wikitable" width="85%"
| |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik
| |
| |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
| |colspan="3" width="25%"| Gegevenselement
| |
| || Waarde
| |
| | |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Identificatie
| |
| |style="background-color: white;"|MBH_323_1_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Registratiedatum
| |
| |style="background-color: white;"|T- 10 dagen, om 11:25
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruik indicator
| |
| |style="background-color: white;"|true
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Gebruiksperiode
| |
| |style="background-color: white;"|Vanaf T- 20 dagen, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Geneesmiddel
| |
| |style="background-color: white;"|ADVIL BRUIS BRUISTABLET 400MG CITRUSSMAAK (code = '2121522' in codeSystem 'G-Standaard HPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |rowspan="4"|
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Omschrijving
| |
| |style="background-color: white;"|Vanaf T- 20 dagen, tot nader order, 3x per dag 1 tablet
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Toedieningsweg
| |
| |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|3 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Auteur
| |
| |style="background-color: white;"|Patiënt
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_323_1
| |
| |}<section end=MGB_XXX_Kilkenny />
| |
| ==Patiënt R. XXX_Ruys== | | ==Patiënt R. XXX_Ruys== |
| <section begin=XXX_Ruys /> | | <section begin=XXX_Ruys /> |
| Regel 3.845: |
Regel 805: |
| |}<section end=XXX_Strengersz /> | | |}<section end=XXX_Strengersz /> |
| ===Medicatieafspraken XXX_Strengersz === | | ===Medicatieafspraken XXX_Strengersz === |
| <section begin=MA_XXX_Strengersz /> | | <section begin=MA_XXX_Strengersz /><section end=MA_XXX_Strengersz /> |
| | ===Verstrekkingsverzoeken XXX_Strengersz === |
| | <section begin=VV_XXX_Strengersz /> |
| {| class="wikitable" width="85%" | | {| class="wikitable" width="85%" |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekkingsverzoek |
| |-style="background-color: #1F497D;; color: white; text-align:left;" | | |-style="background-color: #1F497D;; color: white; text-align:left;" |
| |colspan="3" width="25%"| Gegevenselement | | |colspan="4" width="25%"| Gegevenselement |
| || Waarde | | || Waarde |
|
| |
|
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Identificatie | | |colspan="4"|Identificatie |
| |style="background-color: white;"|MBH_413_1_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | | |style="background-color: white;"|MBH_413_15_VV_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
| | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| | |colspan="4"|Datum |
| | |style="background-color: white;"|T, om 09:35 |
| | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| | |colspan="4"|Auteur |
| | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
| | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| | |colspan="4"|Te verstrekken hoeveelheid |
| | |style="background-color: white;"|100 ml |
| | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| | |colspan="4"|Aantal herhalingen |
| | |style="background-color: white;"|1 |
| | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| | |colspan="5"|Geneesmiddel - Product specificatie |
| | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| | |rowspan="11"| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Afspraakdatum | | |colspan="3"|Product naam |
| |style="background-color: white;"|T, om 11:25 | | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Gebruiksperiode | | |colspan="3"|Omschrijving |
| |style="background-color: white;"|Vanaf T, gedurende 60 dagen | | |style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr |
| | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| | |colspan="4"|Ingredient |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Voorschrijver | | |rowspan="3"| |
| |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Reden afspraak | | |colspan="2"|Ingredient code |
| |style="background-color: white;"|Starten medicamenteuze behandeling (code = '266709005' in codeSystem 'SNOMED CT') | | |style="background-color: white;"|UREUM (code = '15219127' in codeSystem 'G-Standaard HPK') |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Geneesmiddel | | |colspan="2"|Sterkte |
| |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-StandaardGPK') | | |style="background-color: white;"|10 gram per 100 gram |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="4"|Gebruiksinstructie | | |colspan="4"|Ingredient |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |rowspan="4"| | | |rowspan="3"| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="2"|Omschrijving | | |colspan="2"|Ingredient code |
| |style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | | |style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '14740877' in codeSystem 'G-Standaard HPK') |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="2"|Toedieningsweg | | |colspan="2"|Sterkte |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | | |style="background-color: white;"|90 gram per 100 gram |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="2"|Doseerinstructie | | |colspan="4"|Beoogd verstrekker |
| |style="background-color: white;"|1 à 2 maal per dag 1 stuk | | |style="background-color: white;"|Apotheek De Gulle Gaper |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|MBH identificatie | | |colspan="4"|Relatie naar medicatieafspraak |
| |style="background-color: white;"|MBH_413_1 | | |style="background-color: white;"|MBH_413_15_MA_1 |
| |}<section end=MA_XXX_Strengersz /> | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| | |colspan="4"|MBH identificatie |
| | |style="background-color: white;"|MBH_413_15 |
| | |}<section end=VV_XXX_Strengersz /> |
| ===Toedieningsafspraken XXX_Strengersz === | | ===Toedieningsafspraken XXX_Strengersz === |
| <section begin=TA_XXX_Strengersz /> | | <section begin=TA_XXX_Strengersz /><section end=TA_XXX_Strengersz /> |
| | ===Verstrekkingen XXX_Strengersz === |
| | <section begin=MVE_XXX_Strengersz /> |
| {| class="wikitable" width="85%" | | {| class="wikitable" width="85%" |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Verstrekking |
| |-style="background-color: #1F497D;; color: white; text-align:left;" | | |-style="background-color: #1F497D;; color: white; text-align:left;" |
| |colspan="3" width="25%"| Gegevenselement | | |colspan="2" width="25%"| Gegevenselement |
| || Waarde | | || Waarde |
|
| |
|
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Identificatie | | |colspan="2"|Identificatie |
| |style="background-color: white;"|MBH_413_1_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | | |style="background-color: white;"|MBH_413_9_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Afspraakdatum | | |colspan="2"|Datum |
| |style="background-color: white;"|T, om 11:25 | | |style="background-color: white;"|T, om 10:35 |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Gebruiksperiode | | |colspan="2"|Verstrekker |
| |style="background-color: white;"|Vanaf T, gedurende 60 dagen | | |style="background-color: white;"|Apotheek de Gulle Gaper |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Verstrekker | | |colspan="2"|Verstrekte hoeveelheid |
| |style="background-color: white;"|Apotheek De Gulle Gaper | | |style="background-color: white;"|90 stuks |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Geneesmiddel | | |colspan="2"|Geneesmiddel |
| |style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-StandaardGPK') | | |style="background-color: white;"|INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK') |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="4"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |rowspan="4"| | | |colspan="2"|Distributievorm |
| | |style="background-color: white;"|Geïndividualiseerd distributiesysteem (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8') |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="2"|Omschrijving | | |colspan="2"|Relatie naar verstrekkingsverzoek |
| |style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | | |style="background-color: white;"|MBH_413_9_VV_1 |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="2"|Toedieningsweg | | |colspan="2"|MBH identificatie |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen')
| | |style="background-color: white;"|MBH_413_9 |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| | |} |
| |colspan="2"|Doseerinstructie
| |
| |style="background-color: white;"|1 à 2 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|Relatie naar medicatieafspraak
| |
| |style="background-color: white;"|MBH_413_1_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
| |colspan="3"|MBH identificatie
| |
| |style="background-color: white;"|MBH_413_1 | |
| |}<section end=TA_XXX_Strengersz /> | |
| ===Medicatiegebruik XXX_Strengersz ===
| |
| <section begin=MGB_XXX_Strengersz />
| |
| {| class="wikitable" width="85%" | | {| class="wikitable" width="85%" |
| |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatie gebruik | | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Verstrekking |
| |-style="background-color: #1F497D;; color: white; text-align:left;" | | |-style="background-color: #1F497D;; color: white; text-align:left;" |
| |colspan="3" width="25%"| Gegevenselement | | |colspan="4" width="25%"| Gegevenselement |
| || Waarde | | || Waarde |
|
| |
|
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Identificatie | | |colspan="4"|Identificatie |
| |style="background-color: white;"|MBH_413_1_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | | |style="background-color: white;"|MBH_413_15_MVE_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Registratiedatum | | |colspan="4"|Datum |
| |style="background-color: white;"|T, om 16:25 | | |style="background-color: white;"|T, om 10:35 |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Gebruik indicator | | |colspan="4"|Verstrekker |
| |style="background-color: white;"|true | | |style="background-color: white;"|Apotheek de Gulle Gaper |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Volgens afspraak indicator | | |colspan="4"|Verstrekte hoeveelheid |
| |style="background-color: white;"|true | | |style="background-color: white;"|100 gram |
| | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| | |colspan="5"|Geneesmiddel - Product specificatie |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Gebruiksperiode | | |rowspan="11"| |
| |style="background-color: white;"|Vanaf T, gedurende 60 dagen
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Voorschrijver | | |colspan="3"|Product naam |
| |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners | | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Geneesmiddel | | |colspan="3"|Omschrijving |
| |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-StandaardGPK') | | |style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="4"|Gebruiksinstructie | | |colspan="4"|Ingredient |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |rowspan="4"| | | |rowspan="3"| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="2"|Omschrijving | | |colspan="2"|Ingredient code |
| |style="background-color: white;"|Vanaf T, gedurende 60 dagen, 1 à 2 maal per dag 1 stuk, oraal | | |style="background-color: white;"|UREUM (code = '15219127' in codeSystem 'G-Standaard HPK') |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="2"|Toedieningsweg | | |colspan="2"|Sterkte |
| |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | | |style="background-color: white;"|10 gram per 100 gram |
| | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| | |colspan="4"|Ingredient |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="2"|Doseerinstructie | | |rowspan="3"| |
| |style="background-color: white;"|1 à 2 maal per dag 1 stuk
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Gerelateerde afspraak : MA | | |colspan="2"|Ingredient code |
| |style="background-color: white;"|MBH_413_1_MA_1 | | |style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '14740877' in codeSystem 'G-Standaard HPK') |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|Auteur | | |colspan="2"|Sterkte |
| |style="background-color: white;"|Patiënt | | |style="background-color: white;"|90 gram per 100 gram |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="3"|MBH identificatie | | |colspan="4"|Relatie naar verstrekkingsverzoek |
| |style="background-color: white;"|MBH_413_1 | | |style="background-color: white;"|MBH_513_15_VV_1 |
| |}<section end=MGB_XXX_Strengersz /> | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| | |colspan="4"|MBH identificatie |
| | |style="background-color: white;"|MBH_413_15 |
| | |}<section end=MVE_XXX_Strengersz /> |
| | ===Medicatiegebruik XXX_Strengersz === |
| | <section begin=MGB_XXX_Strengersz /><section end=MGB_XXX_Strengersz /> |
